A look at the millions of tax filers who chose the penalty over insurance coverage; the cost of unnecessary or excessively expensive medical care; Takeda begins the first Zika vaccine trial.
In 2015, about 6.7 million tax filers chose to pay the Affordable Care Act's penalty rather than purchase health insurance. An analysis from The New York Times took a look at who these people are and noted that while a tax filer may be an individual or a whole family, the final number is still a fraction of the 29 million Americans who were uninsured. However, more than 12 million tax filers claimed an exemption for 2015 so they didn’t have to pay the penalty for not having insurance. The number of people who paid the penalty in 2015 was down from 8.1 million in 2014.
Unnecessary or excessively expensive medical care costs the US healthcare system more than $200 billion annually. A report from ProPublica delved into waste in the healthcare system, including new supplies being thrown away and arbitrary drug expiration dates. However, it is not easy to stop the wasteful use of procedures and care. Research has also found that unnecessary care happens in the intensive care unit, which is not only expensive, but can be harmful.
The first clinical trial in the development of a vaccine for the Zika virus has started. The US government is backing the clinical trial program by Takeda. Earlier in the year, the government reduced support for development of a vaccine by Sanofi, reported Reuters. Both companies had been working on similar vaccines. Takeda expects results next year from the 240-patient phase I trial. Given the current development timeline, a vaccine likely won’t be ready until after 2020.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More